Revision of Prior Period Financial Statements - Revised Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (28,304)	$ (18,615)	$ (25,686)	$ (13,801)	$ 4,788	$ 20,807	$ (22,977)	$ (13,506)	$ (86,406)	$ (10,888)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization				1,086				452	5,465	2,895
Write-off of inventory				324					1,582	2,132
Adjustment to property and equipment for sales type leases				(625)						(91)
Loss from impairment of property and equipment				96					1,161	1,869
Loss on disposal of property and equipment									0	617
Stock-based compensation				3,927				309	22,498	9,596
Non-cash interest expense				5				2,344	55	5,245
Non-cash lease expense				197					811	0
Provision recorded for allowance for doubtful accounts								(63)	150	(13)
Loss on extinguishment of debt									0	12,685
Change in fair value of derivative liability								1,425	0	1,745
Change in fair value of common stock warrant liability								736	0	879
Change in fair value of contingent earn-out liability				(3,078)					(6,988)	(47,360)
Change in fair value of contingently issuable common stock liability				(1,472)					(1,872)	(6,406)
Change in fair value of public warrant liability				(5,586)					(4,906)	(12,606)
Changes in operating assets and liabilities
Accounts receivable				(2,112)				(874)	(25,593)	(5,063)
Inventory				(1,310)				(480)	(8,495)	(3,436)
Commission assets				(351)				(391)	(3,675)	(3,072)
Contract assets				108				(119)	639	(4,877)
Other assets				141				7	(419)	32
Prepaid expenses and other current assets				(5,571)				(3,727)	(3,174)	(9,148)
Accounts payable				(855)				959	7,661	765
Deferred revenue				2,577				(806)	26,887	4,832
Deferred rent				0				(11)	0	457
Warranty Reserve									0	(42)
Accrued expenses and other current liabilities								1,306		2,472
Accrued expenses and other current liabilities				(2,433)					1,462	2,472
Operating lease liability				(697)					(946)	0
Net cash used in operating activities				(29,430)				(12,439)	(74,728)	(56,781)
Cash flows from investing activities:
Development of internal-use software				(728)					(2,720)	(1,028)
Purchases of property and equipment				(6,689)				(2,121)	(21,473)	(16,557)
Net cash used in investing activities				(7,417)				(2,121)	(23,881)	(17,585)
Cash flows from financing activities:
Proceeds from exercise of stock options				227				455	827	915
Proceeds from issuance of common stock from the PIPE Investment									0	300,000
Proceeds from the closing of the Merger									0	84,945
Payment of offering costs from the closing of the Merger and PIPE Investment									0	(34,132)
Repayment of financing obligations								(359)	0	(359)
Proceeds from long-term debt, net of issuance costs								31,882	29,683	31,882
Repayment of principal on long-term debt									(10,000)	(5,422)
Net cash provided by (used in) financing activities				227				31,978	20,510	377,829
Net increase (decrease) in cash, cash equivalents and restricted cash				(36,620)				17,418	(78,109)	303,463
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period			271,547	308,167			22,122	4,704	308,167	4,704
Cash, cash equivalents and restricted cash at end of period	$ 230,058			271,547	308,167			22,122	230,058	308,167
Supplemental disclosure of cash flow information
Transfer of inventory to property and equipment				0						0
Capital expenditures incurred but not yet paid				2,391				1,335	7,552	2,936
Capitalization of stock compensation									205	53
Issuance of equity classified warrants								1		0
Deferred offering costs included in accounts payable									0	1,943
Conversion of convertible preferred stock to common stock									0	75,877
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger									0	67,021
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger									0	11,670
Conversion of common stock warrants to common stock in connection with the closing of the Merger									0	880
Initial fair value of public warrants in connection with the closing of the Merger									0	23,636
As Previously Reported
Cash flows from operating activities:
Net loss				(14,551)				(13,755)		(10,858)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization				948				452		2,895
Write-off of inventory				324						2,132
Adjustment to property and equipment for sales type leases				(321)						(91)
Loss from impairment of property and equipment				96						1,869
Loss on disposal of property and equipment										617
Stock-based compensation				5,190				1,082		8,511
Non-cash interest expense				5				2,344		5,245
Non-cash lease expense				197
Provision recorded for allowance for doubtful accounts								(63)		(13)
Loss on extinguishment of debt										12,685
Change in fair value of derivative liability								1,425		1,745
Change in fair value of common stock warrant liability								736		879
Change in fair value of contingent earn-out liability				(4,226)						(46,212)
Change in fair value of contingently issuable common stock liability				(1,472)						(6,406)
Change in fair value of public warrant liability				(5,586)						(12,606)
Changes in operating assets and liabilities
Accounts receivable				(2,112)				(874)		(5,063)
Inventory				(6,985)				(433)		(17,479)
Commission assets				(351)				(391)		(3,072)
Contract assets				108				(119)		(4,877)
Other assets				0				0		0
Prepaid expenses and other current assets				(5,280)				(4,104)		(10,079)
Accounts payable				(1,867)				1,194		(7)
Deferred revenue				2,778				(621)		4,968
Deferred rent				(468)				(11)		457
Warranty Reserve										(42)
Accrued expenses and other current liabilities								1,100		5,174
Accrued expenses and other current liabilities				(2,065)
Operating lease liability				(229)
Net cash used in operating activities				(35,867)				(12,038)		(69,628)
Cash flows from investing activities:
Development of internal-use software				(646)						(1,028)
Purchases of property and equipment				(323)				(2,522)		(3,710)
Net cash used in investing activities				(969)				(2,522)		(4,738)
Cash flows from financing activities:
Proceeds from exercise of stock options				216				455		915
Proceeds from issuance of common stock from the PIPE Investment										300,000
Proceeds from the closing of the Merger										84,945
Payment of offering costs from the closing of the Merger and PIPE Investment										(34,132)
Repayment of financing obligations								(359)		(359)
Proceeds from long-term debt, net of issuance costs								31,882		31,882
Repayment of principal on long-term debt										(5,422)
Net cash provided by (used in) financing activities				216				31,978		377,829
Net increase (decrease) in cash, cash equivalents and restricted cash				(36,620)				17,418		303,463
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period			271,547	308,167			22,122	4,704	308,167	4,704
Cash, cash equivalents and restricted cash at end of period				271,547	308,167			22,122		308,167
Supplemental disclosure of cash flow information
Transfer of inventory to property and equipment				4,620						12,949
Capital expenditures incurred but not yet paid				1,693				0		347
Issuance of equity classified warrants								1		1
Deferred offering costs included in accounts payable										1,932
Conversion of convertible preferred stock to common stock										75,877
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger										67,021
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger										11,670
Conversion of common stock warrants to common stock in connection with the closing of the Merger										880
Initial fair value of public warrants in connection with the closing of the Merger										23,636
Adjustment
Cash flows from operating activities:
Net loss				750				249		(30)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization				138				0		0
Write-off of inventory				0						0
Adjustment to property and equipment for sales type leases				(304)						0
Loss from impairment of property and equipment				0						0
Loss on disposal of property and equipment										0
Stock-based compensation				(1,263)				(773)		1,085
Non-cash interest expense				0				0		0
Non-cash lease expense				0
Provision recorded for allowance for doubtful accounts								0		0
Loss on extinguishment of debt										0
Change in fair value of derivative liability								0		0
Change in fair value of common stock warrant liability								0		0
Change in fair value of contingent earn-out liability				1,148						(1,148)
Change in fair value of contingently issuable common stock liability				0						0
Change in fair value of public warrant liability				0						0
Changes in operating assets and liabilities
Accounts receivable				0				0		0
Inventory				5,675				(47)		14,043
Commission assets				0				0		0
Contract assets				0				0		0
Other assets				141				7		32
Prepaid expenses and other current assets				(291)				377		931
Accounts payable				1,012				(235)		772
Deferred revenue				(201)				(185)		(136)
Deferred rent				468				0		0
Warranty Reserve										0
Accrued expenses and other current liabilities								206		(2,702)
Accrued expenses and other current liabilities				(368)
Operating lease liability				(468)
Net cash used in operating activities				6,437				(401)		12,847
Cash flows from investing activities:
Development of internal-use software				(82)						0
Purchases of property and equipment				(6,366)				401		(12,847)
Net cash used in investing activities				(6,448)				401		(12,847)
Cash flows from financing activities:
Proceeds from exercise of stock options				11				0		0
Proceeds from issuance of common stock from the PIPE Investment										0
Proceeds from the closing of the Merger										0
Payment of offering costs from the closing of the Merger and PIPE Investment										0
Repayment of financing obligations								0		0
Proceeds from long-term debt, net of issuance costs								0		0
Repayment of principal on long-term debt										0
Net cash provided by (used in) financing activities				11				0		0
Net increase (decrease) in cash, cash equivalents and restricted cash				0				0		0
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period			$ 0	0			$ 0	0	$ 0	0
Cash, cash equivalents and restricted cash at end of period				0	$ 0			0		0
Supplemental disclosure of cash flow information
Transfer of inventory to property and equipment				(4,620)						(12,949)
Capital expenditures incurred but not yet paid				$ 698				1,335		2,589
Issuance of equity classified warrants								$ 0		(1)
Deferred offering costs included in accounts payable										11
Conversion of convertible preferred stock to common stock										0
Initial fair value of contingent earn-out liability recognized in connection with the closing of the Merger										0
Initial fair value of contingently issuable common stock liability recognized in connection with the closing of the Merger										0
Conversion of common stock warrants to common stock in connection with the closing of the Merger										0
Initial fair value of public warrants in connection with the closing of the Merger										$ 0